Anti-Venom Market Trends 2022-2027

1
Global Anti-Venom Market Research and Forecast
Report 2022-2027




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Anti-Venom Market Research
Report According to the latest report by IMARC
Group, titled Anti-Venom Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2022-2027, the global anti-venom market
reached a strong growth in 2021.  Anti-venom,
also known as anti-venin, refers to a purified
antibody or medicine that prevents or reverses
the snakebite envenoming effects to minimize the
risks of paralysis, loss of limb, or even death
in patients. It is obtained from the antibodies
produced by various animal species, such as
snakes, box jellyfish, stonefish, redback and
funnel-web spiders. It also helps neutralize the
venom to stop it from binding to body tissues,
causing severe allergic reactions,
blood-clotting, kidney damage, muscle injury, and
nervous system problems. Request Free Sample
Report https//www.imarcgroup.com/anti-venom-mark
et/requestsample
4
Report Description and Highlights
Report Description
Global Anti-Venom Market Trends The global
anti-venom market is primarily driven by the
increasing number of deaths due to venomous bites
and stings, especially in rural areas.
Additionally, several favorable initiatives
undertaken by the governing and non-governing
agencies of various countries to spread awareness
regarding snakebite envenoming and available
treatment options have augmented the product
demand. Furthermore, the launch of snake venom
detection kits (SVDKs) with a rapid enzyme
immunoassay for in vitro detection and
immunological identification of snake venom in
samples from bite sites, blood, plasma, urine, or
other tissues and body fluids has accelerated the
product adoption rate. Other factors, including
the rising adoption of polyvalent anti-venoms,
improving healthcare infrastructure,
technological advancements, product innovations,
and ongoing research and development (RD)
activities, are also anticipated to catalyze the
market growth. Looking forward, the market value
is projected to reach a strong growth during the
forecast period (2022-2027).

5
Report Description and Highlights
Report Description

• Market Summary
• Breakup by Species
• Snake
• Scorpion
• Spider
• Others
• Breakup by Anti-venom Type
• Polyvalent Anti-venom
• Monovalent Anti-venom
• Breakup by End User
• Hospitals
• Clinics
• Ambulatory Surgical Centers

6
Report Description and Highlights
Report Description

• Breakup by Mode of Action
• Cytotoxic
• Neurotoxic
• Haemotoxic
• Cardiotoxic
• Myotoxic
• Others

7
Report Description and Highlights
Report Description

• Breakup by Region
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia

8
Report Description and Highlights
Report Description

• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• Note We are updating our reports, If you want
  latest primary and secondary data (2022-2027)
  with Cost Module, Business Strategy, Distribution
  Channel, etc. Click request free sample report.

9
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Bharat Serums and Vaccines Limited (BSV)
• Boehringer Ingelheim International GmbH
• Boston Scientific Corporation
• CSL Limited
• Haffkine Bio-Pharmaceutical Corporation Limited
• Incepta Pharmaceuticals Limited
• Merck Co. Inc.
• Merck KGaA
• MicroPharm Limited
• Pfizer Inc.
• Rare Disease Therapeutics Inc.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/anti-venom-market

10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
13

Contact Us